Analyst Price Target is $18.00
▲ +741.12% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for BriaCell Therapeutics in the last 3 months. The average price target is $18.00, with a high forecast of $18.00 and a low forecast of $18.00. The average price target represents a 741.12% upside from the last price of $2.14.
Current Consensus is
Buy
The current consensus among 1 investment analysts is to buy stock in BriaCell Therapeutics. This Buy consensus rating has held steady for over two years.